HomeBORAY • OTCMKTS
add
Bora Pharmaceuticals American Depository Receipt
Previous close
$3.25
Year range
$3.17 - $5.00
Market cap
59.22B TWD
Avg Volume
212.00
P/E ratio
-
Dividend yield
-
Market news
NDAQ
0.066%
1.88%
2.01%
Financials
Income Statement
Revenue
Net income
| (TWD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 4.86B | -5.15% |
Operating expense | 1.22B | -5.14% |
Net income | 331.76M | -3.87% |
Net profit margin | 6.83 | 1.49% |
Earnings per share | 2.78 | -42.69% |
EBITDA | 784.95M | -19.80% |
Effective tax rate | 47.17% | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.14B | -13.21% |
Total assets | 44.71B | -1.75% |
Total liabilities | 27.24B | -10.93% |
Total equity | 17.47B | — |
Shares outstanding | 126.99M | — |
Price to book | 0.03 | — |
Return on assets | 3.14% | — |
Return on capital | 3.92% | — |
Cash Flow
Net change in cash
| (TWD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 331.76M | -3.87% |
Cash from operations | 1.23B | 604.67% |
Cash from investing | -237.93M | 60.90% |
Cash from financing | -604.84M | -557.84% |
Net change in cash | 667.84M | 267.18% |
Free cash flow | 387.69M | -27.96% |
About
CEO
Founded
2007
Website
Employees
36